Ascletis Pharma Inc
HKEX:1672
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ascletis Pharma Inc
HKEX:1672
|
CN |
|
Ibex Ltd
NASDAQ:IBEX
|
US |
|
Bothra Metals and Alloys Ltd
BSE:535279
|
IN |
|
Ascelia Pharma AB
STO:ACE
|
SE |
|
Mill City Ventures III Ltd
NASDAQ:MCVT
|
US |
|
S
|
Swarna Securities Ltd
BSE:531003
|
IN |
Wall Street
Price Targets
Price Targets Summary
Ascletis Pharma Inc
According to Wall Street analysts, the average 1-year price target for
Ascletis Pharma Inc
is 23.34 HKD
with a low forecast of 13.9 HKD and a high forecast of 33.6 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Ascletis Pharma Inc's stock price target?
Price Target
23.34
HKD
According to Wall Street analysts, the average 1-year price target for
Ascletis Pharma Inc
is 23.34 HKD
with a low forecast of 13.9 HKD and a high forecast of 33.6 HKD.
What is Ascletis Pharma Inc's Revenue forecast?
Projected CAGR
312%
For the last 7 years the
compound annual growth rate for
Ascletis Pharma Inc's revenue is
-41%.
The projected
CAGR
for the next 3 years is
312%.
